Literature DB >> 16167059

Risk factors of myelodysplastic syndromes: a case-control study.

S S Strom1, Y Gu, S K Gruschkus, S A Pierce, E H Estey.   

Abstract

Little is known about the etiology of myelodysplastic syndromes (MDS). A hospital-based case-control study of 354 adult de novo MDS cases and 452 controls was conducted to investigate associations between lifestyle characteristics and MDS risk. The distribution by French-American-British (FAB) type was 67 (19%) refractory anemia (RA), 38 (11%) refractory anemia with ringed sideroblasts (RARS), 43 (12%) chronic myelomonocytic leukemia (CMML), 136 (38%) RA with excess blasts (RAEB), and 70 (20%) RAEB in transformation (RAEBT). Multivariate logistic regression analyses were performed among all MDS cases and among each FAB type and gender. For all MDS combined, family history of hematopoietic cancer (odds ratio (OR) = 1.92), smoking (OR = 1.65), and exposure to agricultural chemicals (OR = 4.55) or solvents (OR = 2.05) were associated with MDS risk. Among RA/RARS cases, smoking (OR = 2.23) and agricultural chemical exposure (OR = 5.68) were the only risk factors identified. For RAEB/RAEBT cases, family history of hematopoietic cancer (OR = 2.10), smoking (OR = 1.52), and exposure to agricultural chemicals (OR = 3.79) or solvents (OR = 2.71) were independent risk factors. Drinking wine reduced risk for all FAB types by almost 50% (OR = 0.54). We found a joint effect between smoking and chemical exposure with the highest risk among smokers exposed to solvents/agricultural chemicals (OR = 3.22). Results from this large study suggest that several factors play a role in MDS predisposition with possible joint effects. Risk profiles seem to differ by FAB type and gender.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167059     DOI: 10.1038/sj.leu.2403945

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  33 in total

1.  Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.

Authors:  Stefani Parmentier; Johannes Schetelig; Kerstin Lorenz; Michael Kramer; Robin Ireland; Ulrich Schuler; Rainer Ordemann; Gabi Rall; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Frank Kroschinsky
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

2.  Obesity, weight gain, and risk of chronic myeloid leukemia.

Authors:  Sara S Strom; Yuko Yamamura; Hagop M Kantarijian; Jorge E Cortes-Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

Review 3.  Alcohol abuse and disorder of granulopoiesis.

Authors:  Xin Shi; Angelo L DeLucia; Jianxin Bao; Ping Zhang
Journal:  Pharmacol Ther       Date:  2019-03-01       Impact factor: 12.310

Review 4.  Epidemiology of myelodysplastic syndromes.

Authors:  Xiaomei Ma
Journal:  Am J Med       Date:  2012-07       Impact factor: 4.965

5.  Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

Authors:  Jenny N Poynter; Michaela Richardson; Michelle Roesler; Cindy K Blair; Betsy Hirsch; Phuong Nguyen; Adina Cioc; James R Cerhan; Erica Warlick
Journal:  Int J Cancer       Date:  2016-09-24       Impact factor: 7.396

Review 6.  A primary care approach to myelodysplastic syndromes.

Authors:  Djamshed Samiev; Vijaya R Bhatt; Joel D Armitage; Lori J Maness; Mojtaba Akhtari
Journal:  Korean J Fam Med       Date:  2014-05-22

7.  Alcohol use is not a significant contributor to myelodysplastic syndromes.

Authors:  Elizabeth A Duffy; Phuong L Nguyen; Adina Cioc; Erica Warlick; Michelle A Roesler; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2020-04-13       Impact factor: 2.506

Review 8.  The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

Authors:  Zaher K Otrock; Ramon V Tiu; Jaroslaw P Maciejewski; Mikkael A Sekeres
Journal:  Expert Rev Hematol       Date:  2013-02       Impact factor: 2.929

9.  Association between mitochondrial DNA haplogroup and myelodysplastic syndromes.

Authors:  Jenny N Poynter; Michaela Richardson; Erica Langer; Anthony J Hooten; Michelle Roesler; Betsy Hirsch; Phuong L Nguyen; Adina Cioc; Erica Warlick; Julie A Ross
Journal:  Genes Chromosomes Cancer       Date:  2016-06-21       Impact factor: 5.006

10.  Obesity, lifestyle factors, and risk of myelodysplastic syndromes in a large US cohort.

Authors:  Xiaomei Ma; Unhee Lim; Yikyung Park; Susan T Mayne; Rong Wang; Patricia Hartge; Albert R Hollenbeck; Arthur Schatzkin
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.